Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
199 participants
OBSERVATIONAL
2021-03-04
2026-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Memory consolidation is the process by which memories become stable, long-term representations in the brain. Consolidation of a motor skill is dependent upon sleep. Some research shows that daytime naps improve people s motor performance and memory retention. Researchers want to find out how daytime naps may contribute to learning and support consolidation of motor skill memories.
Objective:
To learn the role of memory replay during wakeful rest and sleep (naps) in retaining a newly learned skill.
Eligibility:
English-speaking adults ages 18 and older with chronic stroke, or healthy, right-handed, English-speaking adults ages 18-35 and 50-80
Design:
Participants will be screened with:
* medical history
* neurological history
* medicine review
* medical exam
* neurological exam.
Participants will have a magnetic resonance imaging (MRI) scan of the brain. For this, they will lie down in a scanner. The scanner makes loud noises, so they will wear earplugs. They will fill out an MRI screening form before each MRI.
Participants will also have magnetoencephalography (MEG). MEG maps brain activity. It does this by recording the magnetic fields produced by naturally occurring electrical currents in the brain. For MEG, participants will lie down in the MEG room. Their eye movements may be recorded by a video camera.
Participants will have behavior testing. They will practice typing random keys. Then they will repeatedly type a custom sequence that they see on a computer screen. Then they will take a 2-hour nap. Then they will type the same sequence again.
Participants will have no more than 4 visits at the NIH over 3 months. Visits will last 2-4 hours each.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep and Motor Learning in Stroke
NCT05746260
Spaced Versus Massed Skill Learning
NCT00426465
The Influence of the Sleep Apnea on the Neurological and Functional Recovery
NCT01321229
Enhancing Sleep Dependent Consolidation by Non-invasive Brain Stimulation
NCT05843656
Mental Imagery to Reduce Motor Deficits in Stroke
NCT00379392
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We will investigate the within-individual contribution of wakeful and sleep neural replay to motor skill consolidation in three groups: (a) young healthy subjects, (b) older healthy subjects and (c) patients with chronic stroke.
Objectives:
The primary aim is to determine the relative contribution of neural replay during wakeful rest and sleep to consolidation of a newly learned skill in young and older healthy volunteers, and in chronic stroke patients with magnetoencephalography (MEG). The secondary aim is to evaluate differences in replay rates between these subject cohorts. We will also explore differences in replay rates, spatiotemporal dynamics of neural replay and sleep spindles to generate additional hypotheses and preliminary data for future studies.
Endpoints:
The primary endpoint measure is motor skill consolidation (i.e., offline change in correct sequence typing speed following a nap). The secondary endpoint measure is neural replay rate. Exploratory endpoints measures are spatial (i.e. - parcellated source space) and time-frequency maps of neural replay during wakeful rest and sleep, and changes in button-press finger movement kinematics during learning.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1
46 healthy young (18-35) volunteers
No interventions assigned to this group
Arm 2
46 healthy older (50-80) volunteers
No interventions assigned to this group
Arm 3
46 chronic (\>6 months post-stroke) stroke patients
MRI system
MRI system - GE Discovery MR750 3T
MEG system
MEG system The CTF MEG 275 Magnetoencephalography (MEG) scanner system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI system
MRI system - GE Discovery MR750 3T
MEG system
MEG system The CTF MEG 275 Magnetoencephalography (MEG) scanner system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking.
* Clear right-hand dominance (\>74 on Edinburgh Handedness Inventory).
* Normal neurological examination as determined by the screening clinician.
* Age 18 or older
* Willing and able to provide consent
* Experienced a stroke 6 months ago or more that affected at least one of the upper extremities at time of stroke diagnosis
* Ability to perform the study task as assessed during physical examination
* English-speaking
Exclusion Criteria
* Current pregnancy.
* Contraindications for MRI or MEG.
* Use of sleep medications within 24 hours of Experimental Session participation.
* Severe or progressive neurological, psychological or medical condition as determined by the screening clinician.
STROKE PATIENTS:
* HCPS-affiliated NIH staff (i.e. - staff from our section).
* Current pregnancy
* History of large stroke lesions in brainstem or cerebellum as determined by screening clinician
* Severe or progressive neurological disorder other than stroke (e.g., Parkinson s disease or multiple sclerosis) as determined by the screening clinician
* Uncontrolled heart, lung, kidney, gastrointestinal, metabolic, psychiatric, sleep, or endocrine disorders as determined by the screening clinician
* Contraindications for MRI or MEG.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leonardo G Cohen, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Neurological Disorders and Stroke (NINDS)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-N-0060
Identifier Type: -
Identifier Source: secondary_id
200060
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.